文献
J-GLOBAL ID:202002263836766269
整理番号:20A1634565
中国のHER2陽性乳癌の遺伝的突然変異プロファイルとネオアジュバント抗HER2療法に対する応答の遺伝的予測因子【JST・京大機械翻訳】
Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy
著者 (29件):
Li Kai
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Liao Ning
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Liao Ning
(School of Medicine, South China University of Technology, Guangzhou, China)
,
Liao Ning
(The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China)
,
Chen Bo
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Zhang Guochun
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Wang Yulei
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Guo Liping
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Guo Liping
(The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China)
,
Wei Guangnan
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Wei Guangnan
(School of Medicine, South China University of Technology, Guangzhou, China)
,
Jia Minghan
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Wen Lingzhu
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Ren Chongyang
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Cao Li
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Mok Hsiaopei
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Li Cheukfai
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Lin Jiali
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Lin Jiali
(The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China)
,
Chen Xiaoqing
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Chen Xiaoqing
(The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China)
,
Zhang Zhou
(Burning Rock Biotech, Guangzhou, China)
,
Hou Ting
(Burning Rock Biotech, Guangzhou, China)
,
Li Min
(Burning Rock Biotech, Guangzhou, China)
,
Liu Jing
(Burning Rock Biotech, Guangzhou, China)
,
Balch Charles M.
(University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Liao Ning
(Department of Breast Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China)
,
Liao Ning
(School of Medicine, South China University of Technology, Guangzhou, China)
,
Liao Ning
(The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China)
資料名:
Breast Cancer Research and Treatment
(Breast Cancer Research and Treatment)
巻:
183
号:
2
ページ:
321-332
発行年:
2020年
JST資料番号:
W4122A
ISSN:
1573-7217
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)